Early this month Cancer Prevention and Control’s Amy Allen participated in an advanced leadership education program exclusively designed to help nonprofit executives generate added financial support. The “New Strategies” Program is open to nonprofit executives sponsored by corporations or foundations that provide grants to cover all program expenses, including the Forum held on the Georgetown campus. Amy’s participation was sponsored by Bristol-Meyers Squibb Foundation in support of Cancer Prevention and Control’s work to address cancer health disparities.
New Strategies is conducted by Georgetown University's Global Social Enterprise Initiative at the McDonough School of Business. Unlike other programs for nonprofit leaders, New Strategies focuses exclusively on how to bolster and manage revenue for growth and success. Amy identified three of the most powerful lessons to be:
* The role of strategic communications and creative storytelling in the future of fundraising,
* How leading with your issue or cause before brand is most engaging for funders, and
* The significance of partnerships and research in creating mutually beneficial philanthropic and corporate-nonprofit alliances.
The intensive, hands-on experience was directed by nationally recognized leaders in the nonprofit and philanthropy fields and enhanced by Georgetown faculty and MBA teams.
There was a packed house in the Mary Babb Randolph Cancer Center Atrium last Wednesday where several WVU Medicine and Cancer Institute faculty and staff and others gathered to join the Cancer Institute in honoring Dr. Richard Goldberg as the Laurence S. and Jean J. DeLynn Chair of Oncology.
Our West Virginia Program to Increase Colorectal Cancer Screening (WV PICCS) partner clinics participated in national Dress in Blue Day on Friday, March 3. Dress in Blue Day began as a way to present a united front in the battle against the disease during Colorectal Cancer Awareness Month. Partner clinic staff donned their favorite shade a blue in order to raise awareness of colorectal cancer screening with their patients.